Basal and after-stimuli test for prolactinemia in systemic lupus erythematosus

Annals of the New York Academy of Sciences

Volumn 876, Issue , 1999, Pages 155-158

  Zoli, Angelo ^a   Ferlisi, E M ^a   Pompa, A ^a   Barini, A ^a   Altomonte, L ^a   Mirone, L ^a   Magaro M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PROLACTIN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERPROLACTINEMIA; IMMUNE RESPONSE; ORAL DRUG ADMINISTRATION; PROLACTIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032780561     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07634.x     Document Type: Conference Paper

References (8)

1. 1. PIERPAOLI, W. et al. 1976. Interdependence of thymic and neuroendocrine functions in ontogeny. Clin. Exp. Immunol. 25: 501-505.
2. 2. JARA, L. J. et al. 1991. Prolactin, immunoregulation and autoimmune disease. Semin. Arthritis Rheum. 20(5): 273-284.
3. 3. LARREA, F. et al. 1997. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and non stimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J. Clin. Endocrinol. Metab. 82(11): 3664-3669.
4. 4. PELLEGRINI, I. et al. 1992. Expression of prolactin in human lymphoid cells. Mol. Endocrinol. 6: 1023-1031.
5. 5. CLEVENGER, C. V. et al. 1992. Requirement for prolactin during cell cycle regulated gene expression in T lymphocytes. Endocrinology 130: 3216-3222.
6. 6. WALKER, S. E. et al. 1998. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 840: 762-772.
7. 7. ALIEN, S. H. et al. 1996. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 5(1): 30-37.
8. 8. FUNAUCHI, M. et al. 1998. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma. Clin. Exp. Rheumatol. 16(4): 479-482.